For millions of breast cancer survivors, the end of active treatment—surgery, radiation, or chemotherapy—is often viewed as...
Patient Advocacy and Support
TORONTO, ON — As medical advancements continue to improve the survival rates for breast cancer patients, a...
For millions of breast cancer survivors, the conclusion of active treatment—surgery, chemotherapy, and radiation—is often viewed as...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) The landscape of medical treatment is...
OCTOBER 31, 2024 — As the global "Pink October" campaigns draw to a close, the metastatic breast...
TORONTO, ON — As medical advancements continue to improve the survival rates for breast cancer, the healthcare...
By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor agonists have surged...
NEW YORK, NY — As the world enters the midpoint of Breast Cancer Awareness Month, a global...
For millions of breast cancer survivors, the conclusion of active treatment—surgery, chemotherapy, and radiation—is often celebrated as...
TORONTO, ON – As medical advancements continue to improve the survival rates for breast cancer patients across...
